APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging
- PMID: 20065135
- PMCID: PMC2856443
- DOI: 10.1001/archneurol.2009.913
APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging
Abstract
Objective: To study differences in longitudinal changes in regional cerebral blood flow (rCBF) between apolipoprotein E (APOE) epsilon4 carriers and noncarriers in nondemented older adults from the Baltimore Longitudinal Study of Aging using positron emission tomography in order to determine whether there are regionally specific longitudinal changes in rCBF in APOE epsilon4 carriers that might be related to its well-established role as a genetic risk factor for Alzheimer disease.
Design, setting, and participants: Using oxygen 15 ([(15)O])-labeled water positron emission tomography and voxel-based analysis, we compared changes in rCBF over an 8-year period between 29 nondemented APOE epsilon4 carriers and 65 noncarriers older than 55 years. Serial neuropsychological data were collected for all participants.
Results: Widespread differences were observed in longitudinal change in rCBF between epsilon4 carriers and noncarriers. The predominant pattern was greater rCBF decline in epsilon4 carriers. These differences were observed in the frontal, parietal, and temporal cortices. The affected brain regions were those especially vulnerable to pathological changes in Alzheimer disease. Both epsilon4 carriers and noncarriers remained free of clinical diagnoses of dementia or mild cognitive impairment during the course of the study.
Conclusions: Our findings suggest that APOE epsilon4-mediated risk for Alzheimer disease is associated with widespread decline in rCBF over time that precedes the onset of dementia. Accelerated rates of decline in brain function in APOE epsilon4 carriers may contribute to an increased risk for Alzheimer disease and a younger age at onset.
Conflict of interest statement
Conflict of interest: Nothing to disclose
Figures

Similar articles
-
Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.Arch Neurol. 2010 Apr;67(4):462-8. doi: 10.1001/archneurol.2010.30. Arch Neurol. 2010. PMID: 20385913 Free PMC article.
-
Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.JAMA Neurol. 2018 Apr 1;75(4):488-494. doi: 10.1001/jamaneurol.2017.4325. JAMA Neurol. 2018. PMID: 29356823 Free PMC article.
-
18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.Neurobiol Aging. 2014 Sep;35(9):2096-106. doi: 10.1016/j.neurobiolaging.2014.03.006. Epub 2014 Mar 11. Neurobiol Aging. 2014. PMID: 24702820 Free PMC article.
-
Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.J Geriatr Psychiatry Neurol. 2001 Spring;14(1):42-51. doi: 10.1177/089198870101400110. J Geriatr Psychiatry Neurol. 2001. PMID: 11281316
-
Imaging studies and APOE genotype in persons at risk for Alzheimer's disease.Curr Psychiatry Rep. 2006 Feb;8(1):11-7. doi: 10.1007/s11920-006-0076-1. Curr Psychiatry Rep. 2006. PMID: 16513038 Free PMC article. Review.
Cited by
-
Impact of sex and APOE ε4 on age-related cerebral perfusion trajectories in cognitively asymptomatic middle-aged and older adults: A longitudinal study.J Cereb Blood Flow Metab. 2021 Nov;41(11):3016-3027. doi: 10.1177/0271678X211021313. Epub 2021 Jun 8. J Cereb Blood Flow Metab. 2021. PMID: 34102919 Free PMC article.
-
Insulin Resistance, a Risk Factor for Alzheimer's Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach.Biomedicines. 2024 Aug 19;12(8):1888. doi: 10.3390/biomedicines12081888. Biomedicines. 2024. PMID: 39200352 Free PMC article. Review.
-
A methodology for an acute exercise clinical trial called dementia risk and dynamic response to exercise.Sci Rep. 2021 Jun 17;11(1):12776. doi: 10.1038/s41598-021-92177-0. Sci Rep. 2021. PMID: 34140586 Free PMC article. Clinical Trial.
-
Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease.J Cereb Blood Flow Metab. 2015 Jul;35(7):1055-68. doi: 10.1038/jcbfm.2015.76. Epub 2015 Apr 22. J Cereb Blood Flow Metab. 2015. PMID: 25899298 Free PMC article. Review.
-
APOE gene-dependent BOLD responses to a breath-hold across the adult lifespan.Neuroimage Clin. 2019;24:101955. doi: 10.1016/j.nicl.2019.101955. Epub 2019 Jul 22. Neuroimage Clin. 2019. PMID: 31408838 Free PMC article. Clinical Trial.
References
-
- Coon KD, Myers AJ, Craig DW, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007;68:613–618. - PubMed
-
- Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923. - PubMed
-
- Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467–1472. - PubMed
-
- Tiraboschi P, Hansen LA, Masliah E, et al. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology. 2004;62:1977–1983. - PubMed
-
- Modrego PJ. Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Curr Alzheimer Res. 2006;3:161–170. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous